SCHEMBL161534

SCHEMBL161534

CCC(CC)(CP(=O)(O)O)OCCOCCOCCN

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LAP3 P28838 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2417339 1.00 LAP3 (0.31) LAP3
SCHEMBL2413471 0.83 LAP3 (0.31) LAP3
SCHEMBL2414223 0.81 LAP3 (0.34) LAP3
SCHEMBL2870281 0.80
SCHEMBL2415111 0.75 MEN1 (0.43)
SCHEMBL10628363 0.70 LAP3 (0.34) LAP3
SCHEMBL31050122 0.68 LPAR3 (0.35)
SCHEMBL31050148 0.68 LPAR3 (0.35)
SCHEMBL23962261 0.68 ALDH1A1 (0.52)
SCHEMBL10277285 0.68 ALDH1A1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365506-B2 Compounds and compositions as TLR2 agonists NOVARTIS AG (CH) 2016-06-14 US disclosed
WO-2011119759-A1 COMPOUNDS (CYSTEIN BASED LIPOPEPTIDES) AND COMPOSITIONS AS TLR2 AGONISTS USED FOR TREATING INFECTIONS, INFLAMMATIONS, RESPIRATORY DISEASES ETC. IRM LLC (BM) 2011-09-29 WO disclosed